P. Rottoli (Siena, Italy), D. Kirsten (Grosshansdorf, Germany)
Sarcoidosis in Iran - a study of 275 cases
K. Amoli (Tehran, Iran)
|  |
Biochemicals and cells markers in blood and BAL fluid in patients with pulmonary sarcoidosis
M. Preslavova, S. Ivanov, R. Markova (Sofia, Bulgaria)
| |
Serum interleukin 18 as a monitoring marker of long clinical course of pulmonary sarcoidosis
T. Tachibana, H. Okamura, M. Sakatani, E. Ueda (Osaka, Hyogo, Japan)
| |
Clinical manifestations of neurological involvement in sarcoidosis - in our experience
K. Tajima, K. Miura, K. Takahasi, N. Tamura, Y. Fukuti (Tokyo, Japan)
| |
Molecular analysis of bronchoalveolar lavage fluid for Mycobacterium tuberculosis complex DNA and RNA in sarcoidosis patients
S. Chocholska, P. Krawczyk, R. Kieszko, J. Erazmus, J. Milanowski (Lublin, Poland)
| |
The condition of cellular immunity at sarcoidosis
F. A. Mingaleev, A. A. Vizel, N. B. Amirov, F. A. Abdulhaev (Kazan, Russia)
| |
Efficacy and toxicity of azathioprine plus corticosteroids in 32 patients with chronic persistent sarcoidosis
I. Lambiri, W. Schulte, J. Guzman, U. Costabel (Essen, Germany)
| |
Methotrexate in the treatment of the chronic form of pulmonary and extra - pulmonary sarcoidosis
V. V. Mihailovic-Vucinic, J. L. Videnovic, J. Maric-Zivkovic, V. Zugic, S. D. Filipovic (Beograd, Serbia & Montenegro)
| |
Neoplastic markers in pulmonary sarcoidosis
O. S. Tolokh (Lviv, Ukraine)
| |
Serum C-reactive protein concentrations in patients with sarcoidosis: can be taken this simple test as an activation marker in sarcoidosis?
H. Yanardag, H. Yildiz, C. Papila, S. Uygun, Y. Karter (Istanbul, Turkey)
| |
Blood immunological criteria of plasmaferesis success and inflammation activity in sarcoidosis
O. Baklanova, K. Karchevskij, O. Baranova, T. Ses (St Petersburg, Russia)
| |
Diagnosis of sarcoidosis activity
S. E. Borissov, I. P. Solovieva, L. D. Guntupova, E. A. Kupavtzeva, E. V. Goncharova (Moscow, Russia)
| |
Evaluation of two different therapeutic approaches in the management of patients with sarcoidosis: chest x-ray presentation after 12 months prednisone therapy or observation, in 20 years interval (1976-1980 versus 1996-2000)
B. Trzepiora, J. Kozielski, J. Kaminski, D. Ziora (Zabrze, Poland)
| |
Evaluation of cardiac functions by tissue doppler imaging in patients with systemic sarcoidosis
H. Yanardag, I. Keles, G. Alici, F. Aliyev, M. Habeb, B. Ilerigelen, H. Mutlu (Istanbul, Turkey)
| |
The use fluimucil (N-acetylcysteine) in the treatment in patients with III and IY stages of pulmonary sarcoidosis
O. Baranova, T. Kotenko, O. Baklanova (St Petersburg, Russia)
| |
Combined cytotoxic treatment (methotrexate and cyclophosphamide) in association with prednisone in sarcoidosis
S. Mariotta, R. Alberto, P. Bruno, F. Giuseppe, G. Simonetta, S. Bruno, A. Mauro, M. Francesco (Rome, Italy)
| |
Epidemiological particularities in a group of Tunisian sarcoidosic patients
B. Louzir, J. Cherif, H. Zakhama, N. Mehiri, A. Ouadour, M. Beji, J. Daghfous (Tunis, Tunisia)
| |
Sarcoidosis with upper respiratory tract involvement
P. Rottoli, E. Bargagli, C. Chidichimo, G. Caruso, M. Cintorino, D. Nuti (Siena, Italy)
| |
Bone mineral density and calciun metabolism in sarcoidosis at clinical onset
P. Rottoli, M. Martino, U. Maccari, N. Nikiforakis, A. Fossi, R. Filippi, A. Montagnani, C. Cepollaro, R. Nuti, S. Gonnelli (Siena, Italy)
| |